Search research articles
Contact Us
Filters
Showing results (111-120 of 143) with videos related to
Page
of 15
Sort By:
Frontiers in Medicine
|
May 23, 2022
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, et al.
Frontiers in Medicine
|
April 1, 2022
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 13, 2016
How the Human Brain Represents Perceived Dangerousness or "Predacity" of Animals
Andrew C Connolly, Long Sha, J Swaroop Guntupalli, et al.
Molecular Psychiatry
|
March 8, 2022
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Maia L Budziñski, Clara Sokn, Romina Gobbini, et al.
Clinical Lung Cancer
|
August 30, 2024
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
C Huet, C Basse, M Knetki-Wroblewska, et al.
Journal of Medicinal Chemistry
|
July 22, 2008
Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship
Mauro Gobbini, Silvia Armaroli, Leonardo Banfi, et al.
Nature Communications
|
March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Frontiers in Immunology
|
August 1, 2022
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 143) with videos related to
Sort By:
Page
of 15
Frontiers in Medicine
|
May 23, 2022
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, et al.
Frontiers in Medicine
|
April 1, 2022
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study
Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 13, 2016
How the Human Brain Represents Perceived Dangerousness or "Predacity" of Animals
Andrew C Connolly, Long Sha, J Swaroop Guntupalli, et al.
Molecular Psychiatry
|
March 8, 2022
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Maia L Budziñski, Clara Sokn, Romina Gobbini, et al.
Clinical Lung Cancer
|
August 30, 2024
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
C Huet, C Basse, M Knetki-Wroblewska, et al.
Journal of Medicinal Chemistry
|
July 22, 2008
Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship
Mauro Gobbini, Silvia Armaroli, Leonardo Banfi, et al.
Nature Communications
|
March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Frontiers in Immunology
|
August 1, 2022
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Page
of 15